CVE-2025-1001

CVE-2025-1001 is a medium-severity vulnerability with a CVSS 3.x base score of 5.7. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-295.

Key facts

Description

Medixant RadiAnt DICOM Viewer is vulnerable due to failure of the update mechanism to verify the update server's certificate which could allow an attacker to alter network traffic and carry out a machine-in-the-middle attack (MITM). An attacker could modify the server's response and deliver a malicious update to the user.

Frequently asked questions

What is CVE-2025-1001?
Medixant RadiAnt DICOM Viewer is vulnerable due to failure of the update mechanism to verify the update server's certificate which could allow an attacker to alter network traffic and carry out a machine-in-the-middle attack (MITM). An attacker could modify the server's response and deliver a malicious update to the user.
How severe is CVE-2025-1001?
CVE-2025-1001 has a CVSS 3.x base score of 5.7, rated medium severity. It is exploitable over an adjacent network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is none, integrity high, and availability none.
Is CVE-2025-1001 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (3rd percentile), an estimate of the probability of exploitation in the next 30 days.
How do I fix CVE-2025-1001?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2025-1001 have an EU (EUVD) identifier?
Yes. CVE-2025-1001 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-4555.
When was CVE-2025-1001 published?
CVE-2025-1001 was published on 2025-02-21 and last updated on 2026-06-17.

References

Other CWE-295 (Improper Certificate Validation) vulnerabilities

Browse all CWE-295 (Improper Certificate Validation) vulnerabilities →